A nationwide Alzheimer's clinical trial, BenfoTeam, is being locally administered by MedVadis, a partner of Boston Advanced Medicine based in Waltham.
An ongoing clinical trial, BenfoTeam, is being administered in Greater Boston. Researchers hope a lab-made version of thiamine, or Vitamin B1, can help to slow cognitive decline in people with early Alzheimer'sPatients participating will be helping to determine the potential benefits of taking a drug called benfotiamine— which researchers believe may delay or slow the progression of symptoms of early Alzheimer's disease.
A new study is tying high doses of common ADHD treatments like Adderall to increased risk of manic or psychotic episodes. "The research is being done to determine the exact benefits of this drug," DiBenedetto said."Hopefully it's not just slowing down the cognitive decline, but also reversing or improving cognitive function."
He first began noticing his own cognitive decline while living in Florida, before moving back to Massachusetts to be closer to family.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New AI model enhances clinical trial approval predictions by quantifying uncertaintyResearchers from Stanford University and Rensselaer Polytechnic Institute have developed an advanced AI model that improves the prediction accuracy of clinical trial approvals.
Read more »
Clinical trial supports adding ruxolitinib to tyrosine kinase inhibitors for chronic myeloid leukemiaResearchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase inhibitor (TKI) treatment for patients with chronic-phase chronic myeloid leukemia (CP-CML) significantly increased the percentage of patients who had a molecular response deep enough to warrant discontinuing treatment.
Read more »
Clinical trial: Cholesterol drug ineffective for treatment of multiple sclerosisResults of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown that the commonly used high-cholesterol drug simvastatin cannot slow disability progression.
Read more »
Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypesClinical trial results from St. Jude Children's Research Hospital demonstrate the benefits of using genomics and early treatment response to guide risk classification of children with B-cell acute lymphoblastic leukemia (B-ALL).
Read more »
Enhancing the adoption of pragmatic clinical trial results in healthcare systemsA new thought piece led by the Harvard Pilgrim Health Care Institute with collaborators from Duke University and Kaiser Permanente Washington Health Research Institute highlights the challenges facing healthcare researchers and decision makers in the quest to improve population health in a constantly evolving healthcare landscape.
Read more »
Clinical trial finds multidisciplinary approach improves quality of life for movement disorder patientsA research team has published a randomized clinical trial demonstrating for the first time that a multidisciplinary approach integrating specific physiotherapy and cognitive-behavioral therapy is effective in improving the symptoms and physical aspects of the quality of life of patients with functional movement disorders.
Read more »